M. Perry

M. Perry
St George's Healthcare NHS Trust

About

136
Publications
5,752
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
1,217
Citations

Publications

Publications (136)
Article
OBJECTIVE To assess treatment satisfaction and decision regret post robot-assisted radical prostatectomy (RARP) and correlate these with clinical, demographic and quality of life indicators. Our study took place at a high-volume UK centre and patients were assessed at a minimum of 18 months post-surgery. METHODS Patients who underwent RARP between...
Article
Introduction: The standard intravesical treatment for high risk non muscle invasive bladder cancer (HRNMIBC) is Bacillus Calmette-Guérin (BCG), with failure often resulting in cystectomy. Radiofrequency-Induced Thermo-chemotherapeutic Effect Mitomycin (RITE-MMC) can be an alternative in BCG failure. There has been concern that RITE-MMC may delay a...
Article
Retzius-sparing versus Standard Robotic-Assisted Radical Prostatectomy: A Comparative Analysis of functional and oncological outcomes in 500 patients. Kusuma VRM, Vasanthan R, Parekh K, Pavlakis P, Chopra S, D Moschonas, Patil K, Perry M, Eden C Department of Urology Royal Surrey county Hospital Guildford, UK INTRODUCTION AND OBJECTIVES: There...
Article
Full-text available
We aim to outline our technique of performing a robotic-assisted bladder diverticulectomy at our institution and report our surgical outcomes. We report the cases of three robotic-assisted bladder diverticulectomies, performed at the Royal Surrey County Hospital during the period of January 2014 to December 2015. Patient was positioned in low dorsa...
Article
Full-text available
Objectives: We aim to assess if short LoS following robot-assisted radical cystectomy (RARC) with Enhanced Recovery Protocol (ERP) is associated with increased readmission rate and analyse the impact of rehospitalisation in tertiary versus referral hospitals on outcomes. Methods: Between April 2013 and December 2017, 255 (198 male and 57 female) pa...
Conference Paper
1 Eastbourne District General Hospital: East Sussex Healthcare Nhs Trust, Eastbourne, United Kingdom 2 Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom 3 St George's University Hospitals NHS Foundation Trust, London, United Kingdom 4 Brighton and Sussex University Hospitals NHS Trust , Brighton, United Kingdom 5 University Hospital...
Article
INTRODUCTION & OBJECTIVES: Data on the oncological outcomes in patients undergoing robot-assisted radical cystectomy (RARC) is limited. Globally extracorporeal urinary diversion following RARC remains the most common approach despite potential advantages of a completely minimally invasive approach. We report oncological outcomes and associated prog...
Article
Full-text available
INTRODUCTION & OBJECTIVES: Radical cystectomy is associated with frequent morbidity and prolonged length of stay irrespective of surgical approach. There is increasing evidence from colorectal surgery that minimally invasive surgery and enhanced recovery programs (ERPs) can reduce surgical morbidity and length of stay. ERPs are now recognized to be...
Article
INTRODUCTION & OBJECTIVES: Debate remains as to whether Robotic-Assisted Radical Cystectomy (RARC) negatively impacts survival outcomes and in particular, early recurrence patterns. We report early recurrence patterns and identify predisposing factors. MATERIAL & METHODS: Retrospective review of the prospectively populated EAU Robotic Urology Sect...
Article
Introduction and objectives: Radical cystectomy is associated with high complications rates irrespective of surgical approach. Worldwide most centers performing robot-assisted radical cystectomy (RARC) perform an extracorporeal urinary diversion, despite potential advantages of a completely minimally invasive technique. We describe complication out...
Article
Introduction and objectives: Data on the oncological outcomes in patients undergoing robot-assisted radical cystectomy (RARC) is limited. Globally extracorporeal urinary diversion following RARC remains the most common approach despite potential advantages of a completely minimally invasive approach. We report oncological outcomes and associated pr...
Article
Introduction and objectives: Debate remains as to whether robotic-assisted radical cystectomy (RARC) negatively impacts survival outcomes due to inadequate resection or alteration of recurrence patterns due to the pneumoperitoneum. Material and methods: 621 patients with non-metastatic bladder cancer underwent RARC with an intracorporeal urinary di...
Article
Hyperthermic mitomycin (HM) is a novel treatment modality for selected patients with high-risk non-muscle invasive bladder cancer (NMIBC). We sought to determine predictors of response to this therapy. A longitudinal, cohort study of 97 patients with high-risk NMIBC treated with ≥4 HM instillations on a prophylactic schedule was conducted. The prim...
Article
Introduction: With increasing confidence in robot-assisted urinary diversion and its perceived benefit in reducing benign ureteroenteric anastomotic strictures (BUAS),1 we evaluate surgical technique and outcomes between intracorporeal (InC) and extracorporeal (ExC) urinary diversion following radical cystectomy. In this video, we describe the tech...
Article
Full-text available
Introduction & Objectives: Radical cystectomy is the treatment of choice for muscle invasive bladder cancer in fit patients. However, it is associated with significant morbidity and mortality of 48% and 4.2% respectively at 90 days. Median length of stay in UK is 13 days. A carefully designed service combining minimally invasive surgery with an Enh...
Article
Aim The aim of this study was to determine the added value of robotic surgery for radical cystectomy in the context of an established enhanced recovery programme (ERP). Background We have previously reported on ERP in open radical cystectomy (ORC) and shown that it is safe and not associated with an increase in complications or readmissions. Furth...
Article
Background: Dynamic sentinel node biopsy (DSNB) in combination with ultrasound scan (USS) has been the technique of choice at our centre since 2004 for the assessment of nonpalpable inguinal lymph nodes (cN0) in patients with squamous cell carcinoma of the penis (SCCp). Sensitivity and false-negative rates may vary depending on whether results are...
Article
Full-text available
The principal advantage of dynamic sentinel lymph node biopsy (DSNB) over modified inguinal node dissection is the lower complication rate. The aim of this study was to identify factors associated with short-term complications of DSNB in order to lower morbidity of the procedure. Retrospective and prospective cohort studies were performed on patien...
Article
4640 Background: Dynamic sentinel node biopsy (DSNB) in combination with ultrasound scan (USS) has been the technique of choice at our centre since 2004 for the assessment of non palpable inguinal lymph nodes in patients with squamous cell carcinoma of the penis (SCCp). Sensitivity/false-negative rates may vary depending on whether results are repo...
Article
e15100 Background: To establish the response rate of 5-flurouracil (5-FU) and imiquimod (IQ) in the treatment of penile CIS in a large contemporary series in a supra-network center. The use of topical agents in the treatment of CIS of the penis has been well described in the literature. Previous studies have been limited by small sample size and im...
Article
The use of topical agents in the treatment of carcinoma in situ (CIS) of the penis has been well described in the literature. Previous studies have been limited by small sample size and imprecise end points. Establish the response rate of 5-fluorouracil (5-FU) and imiquimod (IQ) in the treatment of penile CIS in a large contemporary series in a sup...